Lucid Diagnostics Inc. Increase (Decrease) in Accounts Receivable
Lucid Diagnostics Inc. (LUCD) reported Increase (Decrease) in Accounts Receivable of $445.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2026-08-12
- Lucid Diagnostics Inc. increase (decrease) in accounts receivable for the quarter ending 2026-06-30 was $399.00K, a 27.88% increase year-over-year.
- Lucid Diagnostics Inc. increase (decrease) in accounts receivable for the quarter ending 2026-03-31 was $46.00K, a 187.50% increase year-over-year.
- Lucid Diagnostics Inc. increase (decrease) in accounts receivable for the quarter ending 2025-12-31 was $96.00K, a 1271.43% increase year-over-year.
- Lucid Diagnostics Inc. increase (decrease) in accounts receivable for the quarter ending 2025-09-30 was $177.00K.
- Lucid Diagnostics Inc. increase (decrease) in accounts receivable for fiscal 2025 was $601.00K.
- Lucid Diagnostics Inc. increase (decrease) in accounts receivable for fiscal 2024 was $0.00, a 100.00% decline from fiscal 2023.
- Lucid Diagnostics Inc. increase (decrease) in accounts receivable for fiscal 2023 was $28.00K.
- Lucid Diagnostics Inc. increase (decrease) in accounts receivable for fiscal 2022 was -$183.00K, a 191.50% decline from fiscal 2021.
| Period end | Increase (Decrease) in Accounts Receivable 3 month | Increase (Decrease) in Accounts Receivable 6 month | Increase (Decrease) in Accounts Receivable 9 month | Increase (Decrease) in Accounts Receivable 12 month |
|---|---|---|---|---|
| 2026-06-30 | $399.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | $445.00K 10-Q · filed 2026-08-12 | $541.00K derived: sum of 3 quarters · filed 2026-08-12 | $718.00K derived: sum of 4 quarters · filed 2026-08-12 |
| 2026-03-31 | $46.00K 10-Q · filed 2026-05-13 | $142.00K derived: sum of 2 quarters · filed 2026-05-13 | $319.00K derived: sum of 3 quarters · filed 2026-05-13 | $631.00K derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-12-31 | $96.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $273.00K derived: sum of 2 quarters · filed 2026-03-25 | $585.00K derived: sum of 3 quarters · filed 2026-08-12 | $601.00K 10-K · filed 2026-03-25 |
| 2025-09-30 | $177.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $489.00K derived: sum of 2 quarters · filed 2026-08-12 | $505.00K 10-Q · filed 2025-11-12 | $512.00K derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-06-30 | $312.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | $328.00K 10-Q · filed 2026-08-12 | $335.00K derived: sum of 3 quarters · filed 2026-08-12 | $213.00K derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-03-31 | $16.00K 10-Q · filed 2026-05-13 | $23.00K derived: sum of 2 quarters · filed 2026-05-13 | -$99.00K derived: sum of 3 quarters · filed 2026-05-13 | $12.00K derived: sum of 4 quarters · filed 2026-05-13 |
| 2024-12-31 | $7.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | -$115.00K derived: sum of 2 quarters · filed 2026-03-25 | -$4.00K derived: sum of 3 quarters · filed 2026-03-25 | $0.00 10-K · filed 2026-03-25 |
| 2024-09-30 | -$122.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$11.00K derived: sum of 2 quarters · filed 2025-11-12 | -$7.00K 10-Q · filed 2025-11-12 | $17.00K derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | $111.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | $115.00K 10-Q · filed 2025-08-12 | $139.00K derived: sum of 3 quarters · filed 2025-08-12 | $125.00K derived: sum of 4 quarters · filed 2025-08-12 |
| 2024-03-31 | $4.00K 10-Q · filed 2025-05-13 | $28.00K derived: sum of 2 quarters · filed 2025-05-13 | $14.00K derived: sum of 3 quarters · filed 2025-05-13 | $22.00K derived: sum of 4 quarters · filed 2025-05-13 |
| 2023-12-31 | $24.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-24 | $10.00K derived: sum of 2 quarters · filed 2025-03-24 | $18.00K derived: sum of 3 quarters · filed 2025-03-24 | $28.00K 10-K · filed 2025-03-24 |
| 2023-09-30 | -$14.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | -$6.00K derived: sum of 2 quarters · filed 2024-11-12 | $4.00K 10-Q · filed 2024-11-12 | -$10.00K derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | $8.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-12 | $18.00K 10-Q · filed 2024-08-12 | $4.00K derived: sum of 3 quarters · filed 2024-08-12 | $35.00K derived: sum of 4 quarters · filed 2024-08-12 |
| 2023-03-31 | $10.00K 10-Q · filed 2024-05-13 | -$4.00K derived: sum of 2 quarters · filed 2024-05-13 | $27.00K derived: sum of 3 quarters · filed 2024-05-13 | -$62.00K derived: sum of 4 quarters · filed 2024-05-13 |
| 2022-12-31 | -$14.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-25 | $17.00K derived: sum of 2 quarters · filed 2024-03-25 | -$72.00K derived: sum of 3 quarters · filed 2024-03-25 | -$183.00K 10-K · filed 2024-03-25 |
| 2022-09-30 | $31.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | -$58.00K derived: sum of 2 quarters · filed 2023-11-13 | -$169.00K 10-Q · filed 2023-11-13 | -$169.00K derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-06-30 | -$89.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | -$200.00K 10-Q · filed 2023-08-14 | -$200.00K derived: sum of 3 quarters · filed 2023-08-14 | |
| 2022-03-31 | -$111.00K 10-Q · filed 2023-05-15 | -$111.00K derived: sum of 2 quarters · filed 2023-05-15 | ||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-14 | $200.00K 10-K · filed 2023-03-14 | ||
| 2021-09-30 | $200.00K 10-Q · filed 2022-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KORU Medical Systems, Inc. (KRMD) | United States | $0.151B | -106.78 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 | |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| Apyx Medical Corp (APYX) | United States | $0.120B | -21.85 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |